about
Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies.Update on new biologics for intractable eosinophilic asthma: impact of reslizumab.Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland.A Charter to Improve Patient Care in Severe Asthma
P2860
Q39423956-BB800343-5431-48F2-922C-0AE841FD1C04Q42332338-46FA8543-8235-47E6-BC5B-EFF52E9BAD0FQ47555559-68DD136F-916A-4158-8AAC-4E6C6E233D5DQ51345374-E2C91AA8-BFB5-4F21-AD9A-2383BBFD698DQ54978294-3E7C87B3-3EC3-45C3-A6C9-23848000452CQ55082118-6F93BFF0-87D1-4AA2-8858-D06D87333652Q58764055-DDEC9F65-9CE1-4265-8D4F-19845C3AAE79
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Improving the diagnosis of eosinophilic asthma.
@en
type
label
Improving the diagnosis of eosinophilic asthma.
@en
prefLabel
Improving the diagnosis of eosinophilic asthma.
@en
P2860
P1476
Improving the diagnosis of eosinophilic asthma.
@en
P2093
Elisabeth H Bel
Hanneke Coumou
P2860
P304
P356
10.1080/17476348.2017.1236688
P577
2016-09-14T00:00:00Z